Johnson & Johnson - Feb 16, 2024 Form 4 Insider Report for CVRx, Inc. (CVRX)

Role
10%+ Owner
Signature
Johnson & Johnson By: /s/ Marc Larkins, Secretary
Stock symbol
CVRX
Transactions as of
Feb 16, 2024
Transactions value $
$2,671
Form type
4
Date filed
3/6/2024, 03:42 PM
Previous filing
Aug 25, 2023
Next filing
Apr 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVRX Common Stock Exercise of in-the-money or at-the-money derivative security $96K +608K +17.39% $0.16* 4.1M Feb 16, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Sale -$96.1K -3.73K -0.09% $25.81 4.1M Feb 16, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1, F2
transaction CVRX Common Stock Options Exercise $37.40 +158 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $44.80 +189 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $39.10 +165 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $28.00 +118 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $16.80 +71 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $5.45 +23 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $20.10 +85 +0% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $180 +758 +0.02% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $116 +489 +0.01% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $138 +584 +0.01% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $71.10 +300 +0.01% $0.24* 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $524 +442 +0.01% $1.19 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $168 +142 +0% $1.19 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $997 +252 +0.01% $3.96 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1
transaction CVRX Common Stock Options Exercise $406 +79 +0% $5.14 4.1M Feb 29, 2024 By Johnson & Johnson Innovation - JJDC, Inc. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVRX Warrant to Purchase Common Stock Exercise of in-the-money or at-the-money derivative security $0 -607K -100% $0.00* 0 Feb 16, 2024 Common Stock 607K $0.16 By Johnson & Johnson Innovation - JJDC, Inc. F1, F3, F4
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -158 -100% $0.00* 0 Feb 29, 2024 Common Stock 158 $0.24 By Johnson & Johnson Innovation - JJDC, Inc F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -189 -100% $0.00* 0 Feb 29, 2024 Common Stock 189 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -165 -100% $0.00* 0 Feb 29, 2024 Common Stock 165 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -118 -100% $0.00* 0 Feb 29, 2024 Common Stock 118 $0.24 By Johnson & Johnson Innovation - JJDC, Inc F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -71 -100% $0.00* 0 Feb 29, 2024 Common Stock 71 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -23 -100% $0.00* 0 Feb 29, 2024 Common Stock 23 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -85 -100% $0.00* 0 Feb 29, 2024 Common Stock 85 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -758 -100% $0.00* 0 Feb 29, 2024 Common Stock 758 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -489 -100% $0.00* 0 Feb 29, 2024 Common Stock 489 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -584 -100% $0.00* 0 Feb 29, 2024 Common Stock 584 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5, F6
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -300 -100% $0.00* 0 Feb 29, 2024 Common Stock 300 $0.24 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -442 -100% $0.00* 0 Feb 29, 2024 Common Stock 442 $1.19 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5, F7
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -142 -100% $0.00* 0 Feb 29, 2024 Common Stock 142 $1.19 By Johnson & Johnson Innovation - JJDC, Inc F1, F5
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -252 -100% $0.00* 0 Feb 29, 2024 Common Stock 252 $3.96 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5, F8
transaction CVRX Stock Option (Right to Buy) Options Exercise $0 -79 -100% $0.00* 0 Feb 29, 2024 Common Stock 79 $5.14 By Johnson & Johnson Innovation - JJDC, Inc. F1, F5, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"), a wholly-owned subsidiary of Johnson & Johnson.
F2 On February 16, 2024, JJDC exercised the Warrant to purchase 607,725 shares of Common Stock and paid the exercise price (adjusted per the net exercise terms of the Warrant) on a cashless basis, resulting in the withholding of 3,725 of the Warrant shares to pay the exercise price and issuance to JJDC of the remaining 604,000 shares.
F3 The Warrant became exercisable for Common Stock upon the closing of the Issuer's initial public offering and was to expire on the earlier of (i) an acquisition or asset transfer involving the Issuer or (ii) 180 days after receipt of the data from the post-market stage of the Issuer's BeAT-HF pivotal trial.
F4 The Warrant was transferred to JJDC from Biosense Webster, Inc., also a wholly-owned subsidiary of Johnson & Johnson, on February 14, 2024.
F5 Fully vested.
F6 174 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
F7 316 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
F8 506 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.
F9 1,185 options previously reported as issued and held by JJDC were previously canceled by the Issuer for no value.